BTMD biote Corp.

Nasdaq biote.com


$ 2.83 $ -0.04 (-1.39 %)    

Monday, 03-Nov-2025 15:59:50 EST
QQQ $ 629.78 $ -3.11 (-0.49 %)
DIA $ 472.70 $ -2.66 (-0.56 %)
SPY $ 681.88 $ -2.29 (-0.33 %)
TLT $ 89.68 $ 0.07 (0.08 %)
GLD $ 366.72 $ 0.05 (0.01 %)
$ 2.83
$ 2.90
$ 2.75 x 400
$ 3.08 x 6,000
$ 2.81 - $ 2.90
$ 2.65 - $ 6.98
72,132
na
139.91M
$ 0.41
$ 4.47
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
2 05-09-2025 03-31-2025 10-Q
3 03-14-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-09-2024 06-30-2024 10-Q
6 05-10-2024 03-31-2024 10-Q
7 03-15-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-29-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-21-2022 03-31-2022 10-Q
15 04-07-2022 12-31-2021 10-K
16 11-24-2021 09-30-2021 10-Q
17 08-17-2021 06-30-2021 10-Q
18 05-20-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 b-riley-securities-downgrades-biote-to-neutral-lowers-price-target-to-4

B. Riley Securities analyst Jeff Van Sinderen downgrades Biote (NASDAQ:BTMD) from Buy to Neutral and lowers the price target...

 biote-lowers-fy2025-sales-guidance-from-202000m-208000m-to-190000m-vs-204667m-est

Biote (NASDAQ:BTMD) lowers FY2025 sales outlook from $202.000 million-$208.000 million to $190.000 million vs $204.667 million ...

 biote-q2-eps-010-beats-006-estimate-sales-4890m-miss-4952m-estimate

Biote (NASDAQ:BTMD) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.06 by 58.73 ...

 biote-affirms-fy2025-sales-guidance-of-20200m-20800m-vs-20531m-est

Biote (NASDAQ:BTMD) affirms FY2025 sales outlook from $202.00 million-$208.00 million to $202.00 million-$208.00 million vs $20...

 biote-q1-eps-037-beats-007-estimate-sales-4899m-beat-4699m-estimate

Biote (NASDAQ:BTMD) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.07 by 428.57...

 biote-sees-fy25-revenue-202m-208m-vs-22718m-est-adj-ebitda-59m-64m

The Company expects the following for fiscal 2025:($ in millions)2025 Guidance Ranges  Revenue$202-$208Adjusted EBITDA2$59-6420...

 biote-q4-2024-gaap-eps-010-inline-sales-49834m-miss-51245m-estimate

Biote (NASDAQ:BTMD) reported quarterly earnings of $0.10 per share which met the analyst consensus estimate. This is a 44.44 pe...

 craig-hallum-maintains-buy-on-biote-lowers-price-target-to-8

Craig-Hallum analyst Alex Fuhrman maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $12 to $8.

 biote-announces-terry-weber-retiring-as-ceo-and-director-and-transitioning-to-strategic-advisor-to-companys-board-of-directors-bret-christensen-to-succeed-as-ceo-and-director-effective-february-1-2025

Terry Weber Retiring as CEO and Director and Transitioning to Strategic Advisor to Company's Board of DirectorsHealth Care ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION